OmRx Oncology
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2033 Gateway Pl Ste 500, San Jose, Calif...Website
www.omrxonc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About OmRx Oncology
OmRx Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OmRx Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at OmRx Oncology
Earning: See what the market has to say on OmRx Oncology recently announced quarterly report
Funding: Get notified immidiatlly once OmRx Oncology has new funding data
Check out if OmRx Oncology is spiking on competitors!
Check if OmRx Oncology has recently received funding, and reach out quickly before it becomes old news!
OmRx Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if OmRx Oncology had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when OmRx Oncology launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at OmRx Oncology
Find 2 more new buyers
Company Profile Activity
Activity Insights
OmRx Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OmRx Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OmRx Oncology.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding OmRx Oncology
OmRx Oncology is a pioneering biopharmaceutical company focused on developing innovative cancer therapies, particularly oral checkpoint inhibitors. Their lead product, OX-4224, is designed to improve access to cancer immunotherapy, especially in regions underserved by traditional treatments. By offering a more affordable and logistics-friendly alte... Read More
